History of JT

Date Events

April 1985

Japan Tobacco Inc. established. (Japanese tobacco market opened to foreign tobacco manufacturers. )

The Business Development Division established to promote new businesses.

The Business Development Division is later reorganized into operational divisions engaged in the foods and pharmaceuticals businesses, finishing in July 1990.

March 1986

Fukuoka and Tosu factories closed and Kita Kyushu factory built to modernize and rationalize tobacco production.

Nine more tobacco factories closed by June 1996 to further rationalize production.

April 1987

Import tariffs on imported cigarettes abolished.

October 1988

"JT" communication name introduced.

July 1991

Head office temporarily relocated from Minato-ku to Shinagawa-ku during construction of new headoffice building.

September 1993

The Central Pharmaceutical Research Institute established to enhance in-house research capabilities.

October 1994

Government releases first tranche of outstanding JT shares for initial public offering (394,276 sharesoffered at 1,438,000 yen apiece).

JT stock listed on the first sections of stock exchanges in Tokyo, Osaka and Nagoya.

November 1994

JT stock listed on stock exchanges in Kyoto, Hiroshima, Fukuoka, Niigata and Sapporo.

May 1995

Head office moved back to Minato-ku from Shinagawa-ku following completion of new head office building.

June 1996

Government releases second tranche of outstanding JT shares (272,390 shares offered at 815,000 yenapiece).

April 1997

JT ends its salt monopoly business in line with abolition of the salt monopoly system.

The Tobacco Mutual Aid Pension scheme integrated into the Employees' Pension scheme.

April 1998

JT signs an agreement with Unimat Corporation on a tie-up regarding soft drink business.

JT later acquires a majority stake in Unimat.

December 1998

JT acquires a majority stake in Torii Pharmaceutical Co., Ltd. through a tender offer.

May 1999

JT acquires the non-U.S. tobacco business of RJR Nabisco Inc.

July 1999

JT acquires the foods business of Asahi Kasei Corporation, including Asahi Foods and seven other subsidiaries.

October 1999

Under a business tie-up between JT and Torii Pharmaceutical Co., Ltd., the two companies' R&D operations related to medical pharmaceuticals are concentrated at JT, while their promotion operations are combined at Torii Pharmaceutical.

March 2003

Sendai, Nagoya and Hashimoto factories closed as a rationalization measure to ensure long-term profitability for the domestic tobacco business.

October 2003

JT repurchases 45,800 own shares to increase its management options.

March 2004

Hiroshima, Fuchu, Matsuyama and Naha factories closed as a rationalization measure to ensure long-term profitability for the domestic tobacco business.

June 2004

Government releases third tranche of outstanding JT shares (289,334 shares offered at 843,000 yen apiece), reducing its stake in JT to the minimum level allowed under law.

November 2004
~ March 2005

JT repurchases 38,184 own shares to increase its management options.

March 2005

Ueda, Hakodate, Takasaki, Takamatsu, Tokushima, Usuki, Kagoshima and Miyakonojo factories closed as arationalization measure to ensure long-term profitability for the domestic tobacco business.

April 2005

JT terminates a licensing contract under which it had exclusive rights to produce and sell Marlboro brand products in Japan and use the Marlboro trademark in the country.

April 2006

JT implements a five-for-one stock split in order to expand the investor base, effective April 1, 2006.

April 2007

JT acquires all outstanding shares of Gallaher Group Plc.

January 2008

JT acquires a majority stake in Katokichi Co., Ltd. through a tender offer.

July 2008

JT concentrates its processed foods operations, including frozen foods operations and seasonings operations, at Katokichi.

March 2009

Kanazawa factory closed as a rationalization measure to establish a more competitive operating structure in the domestic tobacco business.

March 2010

Morioka factory and Yonago factory closed as a rationalization measure to establish a more competitive operating structure in the domestic tobacco business.